United Therapeutics Corporation (UTHR)

LQDA Settles UTHR Disputes for $380.7M, Limits Yutrepia Label

Liquidia shares surge 25% as settlement ends United Therapeutics litigation

SGIOY or UTHR: Which Is the Better Value Stock Right Now?

United Therapeutics and Liquidia Just Ended Their Patent War. Liquidia Stock Popped 42%

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

This Biotech Stock Surges 37% on Patent Settlement. ‘Better Than the Best-Case Scenario.

United Therapeutics Presents New Data at the CHEST 2026 Annual Meeting

Contrasting United Therapeutics (NASDAQ:UTHR) & Intellia Therapeutics (NASDAQ:NTLA)

United Therapeutics (NASDAQ:UTHR) CEO Sells $5,215,025.00 in Stock

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

UTHR Prevails in LQDA's Yutrepia Patent Dispute, Stock Up Nearly 13%

This United Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

United Therapeutics Won Its Patent War and Liquidia Collapsed

Here Are Thursday’s Top Wall Street Analyst Research Calls: BP, Dollar Tree, Exxon Mobil, Lennar, Occidental Petroleum, Rocket Lab, Teva Pharmaceuticals, United Therapeutics, and More

United Therapeutics Stock Rises Following Federal Court Patent Victory Over Liquidia

United Therapeutics (UTHR) Moves 12.6% Higher: Will This Strength Last?

United Therapeutics Corporation Prevails in Patent Litigation Against Liquidia

Liquidia slumps after US court rules for United Therapeutics in patent fight

United Just Pulled The Ultimate Bull Move, As Its Chief Rival Collapsed

United Therapeutics: The Market Sees The Erosion, Not The Refill - Buy